Awarded at the LVI Congreso SEMICYUC 2021 the translational research group in the critically ill patient

• June 8, 2021
• Guillem Cebrian
• No Comments

From 31 May to 4 June 2021, the XNUMXth National Congress of the Spanish Society of Intensive Care, Critical Care and Coronary Units was held in Barcelona (SEMI-YUC).

The translational research group in the critical patient of I3PT has been recognized with both experimental research awards Dr. Juan Gómez Rubí to the best experimental papers presented at the congress.

Awards:

• Lipopolysaccharide (LPS) treatment enhances the regenerative effect of exosomes derived from mesenchymal stem cells. Of the authors: Areny-Balagueró A, Camprubí-Rimblas M, Guillamat-Prats R, Blanch L, Closa D, Artigas A.

Second prize:

• Effects of prolonged antithrombin or argatroban treatment for acute lung injury in rats. Of the authors: Camprubí-Rimblas M, Areny-Balagueró A, Campaña-Duel E, Morales-Quinteros L, Blanch L, Artigas A.